<p>Russia has granted approval for Pzifer Inc to conduct clinical trials in Russia of its experimental antiviral pill to treat Covid-19, a state registry of medicines showed on Tuesday.</p>.<p>The trials conducted on 90 people located in home-like conditions with someone who has symptomatic Covid-19 began on Nov. 12 and will continue until March 2023, the registry's website said.</p>.<p>Pfizer said earlier this month the experimental antiviral pill cut by 89% the chance of hospitalisation or death for adults at risk of severe disease. It hopes to make the pill available globally as quickly as possible.</p>.<p>The pill has the brand name Paxlovid.</p>.<p><strong>Watch latest videos by DH here:</strong></p>
<p>Russia has granted approval for Pzifer Inc to conduct clinical trials in Russia of its experimental antiviral pill to treat Covid-19, a state registry of medicines showed on Tuesday.</p>.<p>The trials conducted on 90 people located in home-like conditions with someone who has symptomatic Covid-19 began on Nov. 12 and will continue until March 2023, the registry's website said.</p>.<p>Pfizer said earlier this month the experimental antiviral pill cut by 89% the chance of hospitalisation or death for adults at risk of severe disease. It hopes to make the pill available globally as quickly as possible.</p>.<p>The pill has the brand name Paxlovid.</p>.<p><strong>Watch latest videos by DH here:</strong></p>